Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

作者：Kohei Shitara, Sun Young Rha, Lucjan Stanislaw Wyrwicz, Takashi Oshima, Nina A. Karaseva, Михаил Анатольевич Осипов, Hisateru Yasui, Hiroshi Yabusaki, Sergey G. Afanasyev, Young Kyu Park, Salah-Eddin Al-Batran, Takaki Yoshikawa, Patricio Eduardo Yanez, Maria Di Bartolomeo, Sara Lonardi, Josep M. Tabernero, Eric Van Cutsem, Yelena Yuriy Janjigian, Do‐Youn Oh, Jianming Xu, Xiao Fang, Chie‐Schin Shih, Pooja Bhagia, Yung‐Jue Bang · 发表于：The Lancet Oncology · 年份：2023 · DOI：10.1016/s1470-2045(23)00541-7 · 被引用次数：384 · 研究领域：Esophageal Cancer Research and Treatment、Gastric Cancer Management and Outcomes、Cancer Immunotherapy and Biomarkers